A missed point in deciphering the viral synergy between herpes simplex virus and HIV.
Lisco
Andrea
A
Vanpouille
Christophe
C
Margolis
Leonid
L
D000212:Acyclovir / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D015497:HIV-1 / Q000187:drug effects*; D006561:Herpes Simplex / Q000150:complications* / Q000188:drug therapy; D018258:Herpesvirus 2, Human / Q000187:drug effects*; D006801:Humans; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use
D000998:Antiviral Agents; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir
Lancet. 2008 Jun 21;371(9630):2109-19
18572080
N Engl J Med. 2008 Apr 10;358(15):1560-71
18337596
N Engl J Med. 2008 Jul 31;359(5):535; author reply 535
18669436
Cell Host Microbe. 2008 Sep 11;4(3):260-270
18779052
Clin Pharmacol Ther. 1993 Dec;54(6):595-605
8275615
PLoS One. 2007 Oct 24;2(10):e1080
17957262
J Biol Chem. 2008 Nov 14;283(46):31289-93
18818198
N Engl J Med. 2007 Feb 22;356(8):790-9
17314338
Lancet Infect Dis. 2008 Aug;8(8):490-7
18652995
Clin Drug Investig. 2008;28(1):47-53
18081360
Lancet. 2008 Oct 11;372(9646):1298; author reply 1298-9
18929897
J Infect Dis. 2007 Nov 15;196(10):1500-8
18008230
J Infect Dis. 2004 Oct 15;190(8):1374-81
15378428
Science. 2007 Jul 27;317(5837):440
17656693
Lancet Infect Dis. 2009 Feb;9(2):74; author reply 74-5
19179220